JP2009525279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525279A5 JP2009525279A5 JP2008552477A JP2008552477A JP2009525279A5 JP 2009525279 A5 JP2009525279 A5 JP 2009525279A5 JP 2008552477 A JP2008552477 A JP 2008552477A JP 2008552477 A JP2008552477 A JP 2008552477A JP 2009525279 A5 JP2009525279 A5 JP 2009525279A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- methyl
- cln
- yloxy
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- BTTNYQZNBZNDOR-UHFFFAOYSA-N 2,4-dichloropyrimidine Chemical compound ClC1=CC=NC(Cl)=N1 BTTNYQZNBZNDOR-UHFFFAOYSA-N 0.000 description 1
- UMEDXWIHROOINS-UHFFFAOYSA-N 2-(4-chloropyrimidin-2-yl)oxy-2-methylbutanoic acid Chemical compound CCC(C(=O)O)(C)OC1=NC=CC(=N1)Cl UMEDXWIHROOINS-UHFFFAOYSA-N 0.000 description 1
- XYVQFUJDGOBPQI-UHFFFAOYSA-N Methyl-2-hydoxyisobutyric acid Chemical compound COC(=O)C(C)(C)O XYVQFUJDGOBPQI-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- WJUMYPRGOJRUPT-UHFFFAOYSA-N methyl 2-(2-chloropyrimidin-4-yl)oxy-2-methylpropanoate Chemical compound COC(=O)C(C)(C)OC1=CC=NC(Cl)=N1 WJUMYPRGOJRUPT-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76355706P | 2006-01-30 | 2006-01-30 | |
| PCT/US2007/002315 WO2007087448A1 (en) | 2006-01-30 | 2007-01-25 | Spiro imidazole derivatives as ppar modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009525279A JP2009525279A (ja) | 2009-07-09 |
| JP2009525279A5 true JP2009525279A5 (enExample) | 2010-03-11 |
Family
ID=37963493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552477A Pending JP2009525279A (ja) | 2006-01-30 | 2007-01-25 | Ｐｐａｒモジュレーターとしてのスピロイミダゾール誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090137610A1 (enExample) |
| EP (1) | EP1979355B1 (enExample) |
| JP (1) | JP2009525279A (enExample) |
| KR (1) | KR20080081359A (enExample) |
| CN (1) | CN101374841A (enExample) |
| AT (1) | ATE478072T1 (enExample) |
| AU (1) | AU2007208156A1 (enExample) |
| BR (1) | BRPI0706771A2 (enExample) |
| CA (1) | CA2627692A1 (enExample) |
| DE (1) | DE602007008524D1 (enExample) |
| ES (1) | ES2350608T3 (enExample) |
| PL (1) | PL1979355T3 (enExample) |
| PT (1) | PT1979355E (enExample) |
| RU (1) | RU2008135128A (enExample) |
| WO (1) | WO2007087448A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE538651T1 (de) | 2006-10-30 | 2012-01-15 | Merck Sharp & Dohme | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB0720126D0 (en) * | 2007-10-15 | 2007-11-28 | Syngenta Participations Ag | Chemical compounds |
| BRPI0920707A2 (pt) | 2008-10-02 | 2015-12-29 | Respivert Ltd | compostos |
| EP2370428B1 (en) | 2008-12-11 | 2016-08-10 | Respivert Limited | P38 map kinase inhibitors |
| GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
| FR2944524B1 (fr) * | 2009-04-17 | 2012-11-30 | Ipsen Pharma Sas | Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament |
| GB0921730D0 (en) | 2009-12-11 | 2010-01-27 | Respivert Ltd | Method of treatment |
| GB0921731D0 (en) | 2009-12-11 | 2010-01-27 | Respivert Ltd | Theraputic uses |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| GB201005589D0 (en) | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
| JP5787977B2 (ja) | 2010-04-08 | 2015-09-30 | レスピバート・リミテツド | Ｐ３８ｍａｐキナーゼ阻害剤 |
| WO2011124923A2 (en) | 2010-04-08 | 2011-10-13 | Respivert Limited | Novel compounds |
| US20140018242A1 (en) * | 2010-05-31 | 2014-01-16 | Syngenta Participations Ag | Method of crop enhancement |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| US20130197028A1 (en) * | 2010-06-25 | 2013-08-01 | Oklahoma Medical Research Foundation | nAChRalpha7 Agonists and nAChRalpha7 Antagonists for Treating Ulcerative Colitis (UC) and Crohn's Disease (CD) |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| JP2013538215A (ja) | 2010-08-31 | 2013-10-10 | エスエヌユー アールアンドディービー ファウンデーション | ＰＰＡＲδアゴニストの胎児再プログラミング用途 |
| US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2925742B1 (en) | 2012-11-16 | 2016-10-26 | Respivert Limited | Kinase inhibitors |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN113461572B (zh) * | 2021-06-30 | 2023-09-19 | 江苏慧聚药业股份有限公司 | 2-(3-溴-5-甲基苯基)乙腈的合成 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2378179A (en) | 2001-08-03 | 2003-02-05 | Pantherix Ltd | Aromatic sulfonamides and their use in treating bacterial diseases |
| US7498323B2 (en) * | 2003-04-18 | 2009-03-03 | Ono Pharmaceuticals Co., Ltd. | Spiro-piperidine compounds and medicinal use thereof |
-
2007
- 2007-01-25 AU AU2007208156A patent/AU2007208156A1/en not_active Abandoned
- 2007-01-25 PL PL07717085T patent/PL1979355T3/pl unknown
- 2007-01-25 RU RU2008135128/04A patent/RU2008135128A/ru not_active Application Discontinuation
- 2007-01-25 JP JP2008552477A patent/JP2009525279A/ja active Pending
- 2007-01-25 ES ES07717085T patent/ES2350608T3/es active Active
- 2007-01-25 CN CNA2007800031722A patent/CN101374841A/zh active Pending
- 2007-01-25 DE DE602007008524T patent/DE602007008524D1/de active Active
- 2007-01-25 PT PT07717085T patent/PT1979355E/pt unknown
- 2007-01-25 BR BRPI0706771-2A patent/BRPI0706771A2/pt not_active IP Right Cessation
- 2007-01-25 KR KR1020087018697A patent/KR20080081359A/ko not_active Ceased
- 2007-01-25 CA CA002627692A patent/CA2627692A1/en not_active Abandoned
- 2007-01-25 EP EP07717085A patent/EP1979355B1/en not_active Not-in-force
- 2007-01-25 US US12/160,302 patent/US20090137610A1/en not_active Abandoned
- 2007-01-25 WO PCT/US2007/002315 patent/WO2007087448A1/en not_active Ceased
- 2007-01-25 AT AT07717085T patent/ATE478072T1/de active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009525279A5 (enExample) | ||
| KR101934096B1 (ko) | 이델라리십의 제조방법 | |
| Ma et al. | An efficient synthesis of 2-aminothiophenes via the Gewald reaction catalyzed by an N-methylpiperazine-functionalized polyacrylonitrile fiber | |
| CN102020633B (zh) | 一种1-(3,5-二氯吡啶-2-基)-吡唑甲酰胺类化合物的制备方法 | |
| US20110082299A1 (en) | Method for the preparation of dabigatran | |
| JP2009543861A5 (enExample) | ||
| JP2013539765A5 (enExample) | ||
| JP2008523130A5 (enExample) | ||
| JP2015523337A5 (enExample) | ||
| CN103896855A (zh) | 一种4-(1-溴代乙基)-5-氟-6-氯嘧啶的合成方法 | |
| JP2016539168A5 (enExample) | ||
| JP2017509581A5 (enExample) | ||
| KR102453655B1 (ko) | 아코티아미드의 개선된 제조방법 | |
| CN104230804A (zh) | 化学发光物aps-5关键中间体的制备方法 | |
| JP2010517998A5 (enExample) | ||
| JP2008201739A (ja) | エダラボンの製造方法 | |
| CN105189467B (zh) | 制备哒嗪酮化合物的方法 | |
| CN102731328B (zh) | 一种盐酸安非他酮的制备方法 | |
| Xu et al. | Efficient synthesis of furoquinolinones using Hendrickson reagent-initiated cascade annulation | |
| JP2009256298A (ja) | ピペリジン−３−イルカーバメート化合物の光学分割方法およびその中間体 | |
| CN108368097A (zh) | 制备苯并噁唑化合物的方法 | |
| CN104926674B (zh) | 一种（Z）-3-二甲氨基-2-苯氧基-α,β-不饱和酰胺及其制备方法 | |
| JP2016540820A5 (enExample) | ||
| JP2008533169A5 (enExample) | ||
| Wang et al. | Concise synthesis of (+)-subersic acid from (−)-Sclareol |